The transaction, structured as a scheme of arrangement under the Companies Act 2006, requires 75% shareholder approval at upcoming general and court meetings. Equals directors have pledged to recommend the deal, citing its fair terms and potential to secure the company’s future in a private environment.
Regulatory approvals are pending from authorities in the U.K., Europe, Turkey, and Belgium. The consortium anticipates the transaction to close by June 2025. Financial advisers include PJT Partners and Rothschild & Co. for the consortium, Perella Weinberg Partners for JC Flowers, and Canaccord Genuity Group Inc. alongside Lazard Inc. for Equals.
